These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incidence and significance of adverse effects of albendazole therapy in patients with a persistent solitary cysticercus granuloma. Rajshekhar V. Acta Neurol Scand; 1998 Aug; 98(2):121-3. PubMed ID: 9724010 [Abstract] [Full Text] [Related]
6. Three day albendazole therapy in patients with a solitary cysticercus granuloma: a randomized double blind placebo controlled study. Chaurasia RN, Garg RK, Agarwall A, Kohli N, Verma R, Singh MK, Shukla R. Southeast Asian J Trop Med Public Health; 2010 May; 41(3):517-25. PubMed ID: 20578537 [Abstract] [Full Text] [Related]
7. Solitary cysticercus granuloma-treatment with albendazole: what is the optimal duration? Singh G, Murthy JM. Neurol India; 2010 May; 58(4):507-8. PubMed ID: 20739782 [No Abstract] [Full Text] [Related]
16. Albendazole therapy in ring lesions of neurocysticercosis. Lowalekar KB. J Assoc Physicians India; 1992 Oct; 40(10):694-6. PubMed ID: 1307363 [Abstract] [Full Text] [Related]
17. Neurocysticercosis. Short course of treatment with albendazole. Alarcón F, Escalante L, Dueñas G, Montalvo M, Román M. Arch Neurol; 1989 Nov; 46(11):1231-6. PubMed ID: 2818259 [Abstract] [Full Text] [Related]
18. Short course of prednisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study. Garg RK, Potluri N, Kar AM, Singh MK, Shukla R, Agrawal A, Verma R. J Infect; 2006 Jul; 53(1):65-9. PubMed ID: 16269179 [Abstract] [Full Text] [Related]